AXOGEN INC
NASDAQ: AXGN (AxoGen, Inc.)
Last update: 4 minutes ago47.83
-1.84 (-3.70%)
| Previous Close | 49.67 |
| Open | 49.20 |
| Volume | 466,601 |
| Avg. Volume (3M) | 1,230,022 |
| Market Cap | 2,571,413,248 |
| Price / Earnings (Forward) | 5.00 |
| Price / Sales | 9.16 |
| Price / Book | 9.74 |
| 52 Weeks Range | |
| Earnings Date | 28 Oct 2026 |
| Profit Margin | -3.68% |
| Operating Margin (TTM) | -3.42% |
| Diluted EPS (TTM) | -0.160 |
| Quarterly Revenue Growth (YOY) | 17.40% |
| Total Debt/Equity (MRQ) | 67.39% |
| Current Ratio (MRQ) | 4.28 |
| Operating Cash Flow (TTM) | 3.62 M |
| Levered Free Cash Flow (TTM) | 2.84 M |
| Return on Assets (TTM) | -0.13% |
| Return on Equity (TTM) | -7.22% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | AxoGen, Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 4.0 |
| Average | 1.17 |
|
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
| % Held by Insiders | 4.84% |
| % Held by Institutions | 86.20% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| First Light Asset Management, Llc | 31 Mar 2026 | 4,002,768 |
| Morgan Stanley | 31 Mar 2026 | 3,122,982 |
| Polar Capital Holdings Plc | 31 Mar 2026 | 1,500,822 |
| Artemis Investment Management Llp | 30 Jun 2026 | 1,396,792 |
| Wasatch Advisors Lp | 30 Jun 2026 | 1,295,949 |
| Fmr Llc | 30 Jun 2026 | 1,222,864 |
| Divisadero Street Capital Management, Lp | 31 Mar 2026 | 1,095,881 |
| Balyasny Asset Management L.P. | 31 Mar 2026 | 1,087,066 |
| Assenagon Asset Management S.A. | 30 Jun 2026 | 1,043,650 |
| Wellington Management Group Llp | 31 Mar 2026 | 964,565 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |